HomeBiotech

Biotech

Cerecor Inc. Announces Pricing of $36.4 Million Public Offering of Common Stock and Pre-Funded Warrants

Cerecor Inc. Announces Pricing of $36.4 Million Public Offering of Common Stock and Pre-Funded Warrants

January 7, 2021

SHAREHOLDER ALERT: WeissLaw LLP Reminds FIII, JWS, BRPA, and CGIX Shareholders About Its Ongoing Investigations

SHAREHOLDER ALERT: WeissLaw LLP Reminds FIII, JWS, BRPA, and CGIX Shareholders About Its Ongoing Investigations

January 7, 2021

Cologne Higher Regional Court grants approval of capital increase

Cologne Higher Regional Court grants approval of capital increase

January 7, 2021

Catayst (CPRX) Provides Long-Term Portfolio Expansion Plans

Catayst (CPRX) Provides Long-Term Portfolio Expansion Plans

January 7, 2021

RedHill’s (RDHL) RHB-204 Gets FDA Fast Track Designation

RedHill’s (RDHL) RHB-204 Gets FDA Fast Track Designation

January 7, 2021

CNS Pharmaceuticals to Present at the H.C. Wainwright BioConnect 2021 Conference

CNS Pharmaceuticals to Present at the H.C. Wainwright BioConnect 2021 Conference

January 7, 2021

Zacks.com featured highlights include: Bellicum Pharmaceuticals, Prometic Life Sciences, Vaccinex, Meridian Bioscience and 360 DigiTech

Zacks.com featured highlights include: Bellicum Pharmaceuticals, Prometic Life Sciences, Vaccinex, Meridian Bioscience and 360 DigiTech

January 7, 2021

Eiger BioPharmaceuticals Updates on 2020 Progress and 2021 Plans

Eiger BioPharmaceuticals Updates on 2020 Progress and 2021 Plans

January 7, 2021

AzurRx BioPharma to Participate in Biotech Showcase Digital 2021 Conference

AzurRx BioPharma to Participate in Biotech Showcase Digital 2021 Conference

January 7, 2021

ImmuCell Announces Preliminary, Unaudited Sales Results for the Year Ended December 31, 2020

ImmuCell Announces Preliminary, Unaudited Sales Results for the Year Ended December 31, 2020

January 7, 2021

« 1 … 662 663 664 665 666 … 692 »